PLATINUM QCAHome > PtCr Clinical Programs
Platinum Chromium (PtCr) Clinical Programs:
Confidence and Consistency
Boston Scientific demonstrates excellent outcomes with the Element Stent Series through the PLATINUM QCA and PERSEUS Global Clinical Programs.
To learn more about PLATINUM QCA and PERSEUS, watch the short video below or click on the links to the left for more specific program information.
PLATINUM QCA Global Clinical Program
The PLATINUM QCA Global Clinical Program is designed to evaluate the safety and effectiveness of the PROMUS™ Element™ Everolimus-Eluting Coronary Stent for the treatment of up two de novo atherosclerotic coronary lesions.
Learn more
PERSEUS Global Clinical Program
The PERSEUS Global Clinical Program is designed to evaluate the safety and effectiveness of the TAXUS™ Element™ Paclitaxel-Eluting Coronary Stent for the treatment of up to two de novo atherosclerotic coronary lesions. Learn more
[6342]
Print This Page
Not intended for use in the United States and Japan. Stent illustrations not indicative of clinical performance. The TAXUS™ Element™ Drug-Eluting Stent System is CE mark pending, not available for sale in the European Economic Area (EEA). Element™ Bare Metal Stent (BMS) is under development, not available for sale in the European Economic Area (EEA). The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.
All cited trademarks are the property of their respective owners. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, precautions and instructions for use can be found in the product labeling with each device. Information for the use only in countries with applicable health authority product registrations.
Please note that access to the following pages, containing certain information, is exclusively reserved for healthcare professionals. More >>